Rajesh Shinde
Sales & Marketing at ZOTA HEALTH CARE LIMITED
Profile
Rajesh Shinde is currently working as the Manager-National Sales at Zota Health Care Ltd.
since 2016.
Prior to this, he worked as the Manager-National Sales at Astra IDL Ltd.
and as the Manager-Area Business at Emcure Pharmaceuticals Ltd.
Rajesh Shinde active positions
| Companies | Position | Start |
|---|---|---|
| ZOTA HEALTH CARE LIMITED | Sales & Marketing | 2016-01-11 |
Former positions of Rajesh Shinde
| Companies | Position | End |
|---|---|---|
Emcure Pharmaceuticals Ltd.
 Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | Corporate Officer/Principal | - |
| Astra IDL Ltd. | Sales & Marketing | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ZOTA HEALTH CARE LIMITED | Health Technology |
| Private companies | 2 |
|---|---|
| Astra IDL Ltd. | Health Technology |
Emcure Pharmaceuticals Ltd.
Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | Health Technology |
- Stock Market
- Insiders
- Rajesh Shinde
